These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. Karacorlu M; Karacorlu S; Ozdemir H; Mat C Am J Ophthalmol; 2002 Sep; 134(3):360-6. PubMed ID: 12208247 [TBL] [Abstract][Full Text] [Related]
24. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration. Isola V; Pece A; Brancato R Retina; 2004 Aug; 24(4):618-20. PubMed ID: 15300088 [No Abstract] [Full Text] [Related]
25. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Bressler NM Am J Ophthalmol; 2002 Jan; 133(1):168-9. PubMed ID: 11755871 [No Abstract] [Full Text] [Related]
26. Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide. Peiretti E; Klancnik JM; Spaide RF; Yannuzzi L Retina; 2005; 25(3):377-9. PubMed ID: 15805922 [No Abstract] [Full Text] [Related]
27. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease. Andrade RE; Farah ME; Costa RA Am J Ophthalmol; 2003 Dec; 136(6):1179-81. PubMed ID: 14644242 [TBL] [Abstract][Full Text] [Related]
28. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954 [TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to focal laser photocoagulation for radiation retinopathy. Bakri SJ; Beer PM Ophthalmic Surg Lasers Imaging; 2003; 34(6):475-7. PubMed ID: 14620753 [TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy in patients with idiopathic choroidal neovascularization. Karacorlu M; Karacorlu S; Ozdemir H Jpn J Ophthalmol; 2004; 48(4):422-4. PubMed ID: 15295678 [No Abstract] [Full Text] [Related]
31. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy. Ladd BS; Solomon SD; Bressler NM; Bressler SB Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027 [TBL] [Abstract][Full Text] [Related]
33. Successful photodynamic therapy with verteporfin for recurrent choroidal neovascularization beneath the new fovea after macular translocation surgery with 360-degree retinotomy. Sawa M; Chan WM; Ohji M; Imai K; Fujikado T; Tano Y; Schachat AP Am J Ophthalmol; 2003 Sep; 136(3):560-3. PubMed ID: 12967821 [TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy. Wang LK; Kansal S; Pulido JS Am J Ophthalmol; 2002 Nov; 134(5):790-2. PubMed ID: 12429271 [TBL] [Abstract][Full Text] [Related]
35. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA; Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056 [TBL] [Abstract][Full Text] [Related]
36. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A Retina; 2006; 26(9):988-93. PubMed ID: 17151484 [TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. Shaikh S; Ruby AJ; Williams GA Am J Ophthalmol; 2003 Jan; 135(1):1-6. PubMed ID: 12504689 [TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA; Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802 [TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy for choroidal neovascularization after thermal laser photocoagulation for diabetic macular edema. Shah GK Am J Ophthalmol; 2003 Jan; 135(1):114-6. PubMed ID: 12504717 [TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy increases the eligibility for feeder vessel treatment of choroidal neovascularization caused by age-related macular degeneration. Piermarocchi S; Lo Giudice G; Sartore M; Friede F; Segato T; Pilotto E; Midena E Am J Ophthalmol; 2002 Apr; 133(4):572-5. PubMed ID: 11931801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]